Ubiquitous Healthcare Service With Multifactorial Intervention in Diabetes Care
NCT ID: NCT02025296
Last Updated: 2014-10-15
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
100 participants
INTERVENTIONAL
2013-12-31
2014-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ubiquitous Healthcare for Elderly Patients With Type 2 Diabetes Mellitus
NCT01137058
Using Remote Monitoring to Address Health Disparities in Type 2 Diabetes
NCT06517576
A Study to Evaluate the Efficacy of Diabetes Management Based on Ubiquitous Healthcare System
NCT03033407
Patient-Centered Smartphone-Based Diabetes Care
NCT02313363
Individualized Automatic Target Coaching Message for Glycemic Management and Depressive Symptom
NCT06525454
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
A few studies showed that adopting a u-healthcare system helped patients improve their blood glucose control and reduced hypoglycemia or weight gain. In a previous study, supervised telemonitoring was effective for blood pressure control in hypertensive patients in primary care settings. A recent study showed that telemonitoring with pharmacist's help achieved better blood pressure control compared with usual care during 12 months of intervention.
A clinical decision support system (CDSS) is the key to this system, building up an individualized CDSS rule engine is the crux of the u-healthcare system because current glucose control status, antidiabetic medications, lifestyle, and severity of hypoglycemia vary between individual patients.
Recently, our u-healthcare team generated a new multidisciplinary u-healthcare system by upgrading the CDSS rule engine, and integrating a physical activity-monitoring device and dietary feedback into a comprehensive package. With this integrated system, we investigate the effect of individualized multidisciplinary u-healthcare service combined with exercise monitoring and dietary feedback on glucose control with less hypoglycemia in Korean elderly population.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Self-Monitoring of Blood Glucose
measurement of their blood glucose level using a glucometer at least eight times a week
No interventions assigned to this group
U-healthcare
individualized multidisciplinary u-healthcare service combined with exercise monitoring and dietary feedback on glucose control
U-healthcare
use of a public switched telephone network (PSTN)-connected glucometer to measure their blood glucose level at the same frequency as the SMBG group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
U-healthcare
use of a public switched telephone network (PSTN)-connected glucometer to measure their blood glucose level at the same frequency as the SMBG group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Glycated hemoglobin (HbA1c) levels: 7.0-10.5%
Exclusion Criteria
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Bundang Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Soo Lim
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Soo Lim, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
SNUBH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SNUBH
Seongnam-si, Gyeonggi-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
U-healthcare system
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.